A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
about
Prime-boost approaches to tuberculosis vaccine developmentThe HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunityBoosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis.Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice.The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in miceLow cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro.ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.Pro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule.The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice.Systems approach to tuberculosis vaccine development.Recombinant BCG: Innovations on an Old Vaccine. Scope of BCG Strains and Strategies to Improve Long-Lasting MemoryPrime-boost vaccination strategy with bacillus Calmette-Guérin (BCG) and liposomized alpha-crystalline protein 1 reinvigorates BCG potency.Adjunctive immunotherapy with α-crystallin based DNA vaccination reduces Tuberculosis chemotherapy period in chronically infected mice.A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity.Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination.Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
P2860
Q27024526-C6417F2B-D384-4565-9D11-9605D9A9BB6FQ28727776-2EEF439E-D6E5-4916-81A6-4E9DB4C8408AQ30376072-DCE27543-B604-43DD-AD3A-43D16FC6B0B8Q34053027-5803AFB1-6A7D-4D50-971A-AA8A70525649Q34261521-4554555D-BE5A-4EA5-A15A-04FFB2A2D861Q34565122-7070123E-841A-4D2E-B0B3-B920F020EEA5Q35069386-6FE18593-3ACE-450E-B31D-35E1F6803A07Q35514492-8B9C3395-2F34-4700-A85A-E6C82E03FA19Q36439241-E4439FA9-0D80-4028-B824-A68781A7B4DBQ36949611-43E5F129-A5BA-4260-8AC1-BDC9D6AF3658Q38075096-BCC11120-7A82-4CDC-8E18-B412A6C69078Q38207991-3E37E220-5878-4A26-B0FD-0AD641C2BD80Q39021341-FAE2EF17-B120-461A-BA55-65238C1D8036Q40608583-E581F0D7-653C-4477-8DD9-AB5B5D3202A7Q41922740-A2AA9297-500F-4FE6-B348-B784604D126CQ42210000-19BCC676-75F0-4D23-87F5-F63F6928DAC3Q47155139-F6A83578-5146-4A38-85DD-C741741301D0Q47834561-42F40DDA-4A27-4C19-AA5B-4EE9FF457731
P2860
A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A booster vaccine expressing a ...... otection against tuberculosis.
@ast
A booster vaccine expressing a ...... otection against tuberculosis.
@en
type
label
A booster vaccine expressing a ...... otection against tuberculosis.
@ast
A booster vaccine expressing a ...... otection against tuberculosis.
@en
prefLabel
A booster vaccine expressing a ...... otection against tuberculosis.
@ast
A booster vaccine expressing a ...... otection against tuberculosis.
@en
P2093
P2860
P1433
P1476
A booster vaccine expressing a ...... otection against tuberculosis.
@en
P2093
Anil K Tyagi
Bappaditya Dey
Ruchi Jain
Umesh D Gupta
V D Ramanathan
V M Katoch
P2860
P304
P356
10.1371/JOURNAL.PONE.0023360
P407
P577
2011-08-17T00:00:00Z